Aarti Drugs Ltd.

•

aartidrugs.comBSE: 524348NSE: AARTIDRUGS

Market Cap₹ 3,871 Cr.

Current Price

High / Low₹ 535 / 319

Stock P/E22.6

Book Value₹ 159

Price to Book2.48

Dividend Yield0.47 %

ROCE13.5 %

ROE13.0 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.59x)
Company generates healthy free cash flow
Company comfortably covers its interest (7.2x coverage)
Company has a consistent dividend-paying track record
Company maintains a comfortable, low leverage position

CONS

Recent results are weak - TTM profit is down 22.6% versus prior year
Company has delivered a poor profit growth of 3.0% over past five years
Company has delivered a poor sales growth of 5.9% over past five years
Growth is decelerating - 3Y profit CAGR (-6.9%) trails the 5Y trend (3.0%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY MICROCAP250 NIFTY TOTAL MKT

S.No.	Name
1.	SUNPHARMA	1868.50	37.06	448315.74	0.86	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9482.75	86.06	251737.22	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4931.90	86.01	187593.62	0.77	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1129.00	24.95	112618.18	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1368.00	32.79	110515.04	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1933.25	95.54	104455.86	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	AUROPHARMA	1690.00	26.19	97238.86	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
8.	LUPIN	2092.00	17.30	95660.02	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
9.	DRREDDY	1143.20	29.61	95420.61	0.70	435.60	-69.10	8099.80	-5.21	13.75	10.63
10.	MANKIND	2266.00	45.82	93596.02	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2439.55	38.29	68850.12	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	AARTIDRUGS	424.15	20.25	3871.22	0.47	50.13	-7.12	702.78	19.01	13.11	13.97

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	592	578	538	560	493	543	515	623	521	579	529	632	627
	520	512	478	490	439	484	454	534	457	504	486	552	558
Operating Profit	72	65	60	69	54	60	60	89	64	75	42	79	70
OPM %	12.15%	11.33%	11.10%	12.34%	11.00%	10.96%	11.71%	14.23%	12.28%	12.99%	8.00%	12.55%	11.11%
	1	1	2	1	0	0	11	2	0	0	1	1	2
Interest	8	8	7	8	7	7	8	7	7	6	7	7	7
Depreciation	12	12	12	12	12	12	12	12	12	14	15	15	15
Profit before Tax	53	47	43	50	35	41	52	71	45	56	22	59	68
Tax %	25.45%	26.16%	26.24%	27.34%	23.46%	25.68%	25.95%	13.02%	-7.52%	25.10%	-55.87%	23.22%	25.06%
Net Profit	40	35	32	36	27	30	39	61	49	42	34	45	51
	4.27	3.75	3.44	3.93	2.93	3.33	4.22	6.74	5.33	4.58	3.71	4.93	5.57

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	1,075	1,089	1,140	1,454	1,635	1,915	2,251	2,498	2,267	2,174	2,367
	900	910	955	1,252	1,387	1,511	1,930	2,212	1,998	1,908	2,100
Operating Profit	176	179	185	203	248	404	321	286	269	265	267
OPM %	16.34%	16.44%	16.23%	13.94%	15.17%	21.12%	14.27%	11.45%	11.87%	12.20%	11.26%
	0	4	1	6	9	7	5	2	4	14	4
Interest	47	38	36	41	36	26	23	36	33	32	26
Depreciation	36	37	38	40	47	48	47	47	48	48	59
Profit before Tax	93	108	112	128	175	338	255	205	192	199	204
Tax %	28.60%	29.97%	34.58%	31.63%	22.46%	23.69%	23.68%	25.39%	26.29%	20.85%	15.92%
Net Profit	66	75	73	87	136	258	195	153	142	157	171
EPS	27.37	30.84	30.67	37.42	14.53	27.65	21.04	16.50	15.43	17.24	—
Dividend Payout %	24.66%	3.16%	3.21%	2.70%	3.43%	9.04%	4.75%	6.06%	6.48%	5.80%	—

COMPOUNDED SALES GROWTH

10 Years:: 7%
5 Years:: 6%
3 Years:: -1%

COMPOUNDED PROFIT GROWTH

10 Years:: 7%
5 Years:: 3%
3 Years:: -7%

STOCK PRICE CAGR

10 Years:: 14%
5 Years:: -6%
3 Years:: -11%
1 Year:: -14%

RETURN ON EQUITY

10 Years:: 20%
5 Years:: 19%
3 Years:: 13%
Last Year:: 13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	24	24	24	24	23	93	93	93	92	91
	326	363	410	495	598	766	880	1,022	1,083	1,160
	475	460	528	481	383	340	526	648	413	470
Trade Payables	164	170	240	228	316	293	416	419	393	373
	65	99	115	145	149	144	120	14	190	179
Total Liabilities	1,055	1,116	1,316	1,373	1,471	1,637	2,035	2,195	2,172	2,273
	463	542	564	586	612	631	649	634	722	761
Capital Work in Progress	34	14	28	32	11	16	60	161	222	273
	11	18	17	19	20	24	28	29	30	42
	167	189	254	228	307	390	488	478	442	407
	0	0	0	0	0	0	0	0	644	702
Cash & Bank	5	4	4	5	4	4	2	3	4	5
	375	348	449	503	517	572	807	891	108	82
Total Assets	1,055	1,116	1,316	1,373	1,471	1,637	2,035	2,195	2,172	2,273

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	145	194	84	176	233	242	120	217	337	220
Cash from Investing	-87	-96	-71	-59	-29	-69	-125	-131	-187	-135
Cash from Financing	-37	-78	9	-87	-168	-85	84	-31	-149	-85
	1	-0	-0	1	-1	-0	-1	0	1	1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	55.67	55.64	55.38	55.48	55.22	54.72	55.03	55.03	54.43
	2.95	2.50	2.28	2.25	2.26	2.68	2.15	1.57	1.52
	7.35	7.83	8.77	9.70	9.94	9.90	10.12	10.22	10.29
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	34.02	34.02	33.57	32.57	32.58	32.69	32.70	33.18	33.75

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-03

Copy of Newspaper Publication

2026-09-03 - Aarti Drugs Limited has informed the Exchange about Copy of Newspaper Publication

2026-09-02

Updates

2026-09-02 - Aarti Drugs Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for FY 2025-26 '.

2026-09-02

Shareholders meeting

2026-09-02 - Aarti Drugs Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 26, 2026

2026-09-01

Copy of Newspaper Publication

2026-09-01 - Aarti Drugs Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-27

Outcome of Board Meeting

2026-08-27 - Aarti Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on August 27, 2026.

2026-08-24

Trading Window

2026-08-24 - Aarti Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

2026-08-14

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-14 - Aarti Drugs Limited has informed the Exchange about Schedule of meet

2026-08-10

Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

2026-08-10 - Aarti Drugs Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

2026-08-07

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-07 - Aarti Drugs Limited has informed the Exchange about Transcript

News

Recent coverage and analyst commentary for AARTIDRUGS

Loading news…

🤖

AI Stock Analyst

Aarti Drugs Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account